Effects of pindolol and methyldopa on blood pressure and plasma norepinephrine
- 31 August 1982
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 104 (2) , 425-431
- https://doi.org/10.1016/0002-8703(82)90134-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- MethyldopaArchives of internal medicine (1960), 1980
- Differential Effects of Long-Term Cardioselective and Nonselective Beta-Receptor Blockade on Plasma Catecholamines During and After Physical Exercise in Hypertensive PatientsJournal of Cardiovascular Pharmacology, 1980
- Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertensionThe American Journal of Medicine, 1978
- Experience with pindolol, a betareceptor blocker, in the treatment of hypertensionThe American Journal of Medicine, 1976
- EFFICACY OF ANTIHYPERTENSIVE DRUGSThe Lancet, 1976
- The use of pindolol in the treatment of essential hypertension: a multi-centre assessmentCurrent Medical Research and Opinion, 1976
- Centrally induced hypotensive effects of β-adrenergic blocking drugsEuropean Journal of Pharmacology, 1975
- POSSIBLE ROLE OF A β‐ADRENOCEPTOR IN THE REGULATION OF NORADRENALINE RELEASE BY NERVE STIMULATION THROUGH A POSITIVE FEED‐BACK MECHANISMBritish Journal of Pharmacology, 1975
- The mechanism of the antihypertensive action of α-methyldopa in hypertensive ratsEuropean Journal of Pharmacology, 1973
- Clinical and Chemical Studies with α -Methyl-Dopa in Patients with HypertensionCirculation, 1962